Shareholders Approve Astronomical Share Capital Increase and Extreme Reverse Split Authorization
HAO sits 45% above its 52-week low of $0.78 on light trading volume (0.3× avg).
Summary
Haoxi Health shareholders approved an astronomical increase in authorized shares and granted the board discretion for another extreme reverse stock split, indicating severe potential dilution and ongoing share price instability.
Key Events · Corporate Governance and Compliance · HAO
-
Astronomical Share Capital Increase Approved
Shareholders voted to increase authorized Class A ordinary shares to 100 trillion and Class B ordinary shares to 10 trillion, a dramatic expansion of potential future dilution.
-
Extreme Reverse Split Authorization
The board gained approval to implement one or more reverse stock splits with an aggregate ratio of up to 1-for-8,000 within the next two years, following a recent 1:128 reverse split.
-
Amended Charter Adopted
The company's memorandum and articles of association were updated to reflect the approved share capital increase and quorum changes.
Analysis · HAO · Trade & Services
Shareholders have approved an unprecedented increase in authorized share capital, allowing the company to issue trillions of new shares. This move, coupled with the authorization for the board to implement a reverse stock split of up to 1-for-8,000, signals the company's preparation for potentially massive future dilution. This follows a recent 1:128 reverse split and a $6.5 million offering, indicating persistent financial challenges and a need for extreme flexibility in capital raising, which could severely devalue existing shares.
At the time of this filing, HAO was trading at $1.13 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $2.2M. The 52-week trading range was $0.78 to $285.44. This filing was assessed with negative market sentiment and an importance score of 10 out of 10.